
Scientists have found five key signs of Alzheimer’s that can be detected up to 25 years before the onset of the degenerative disease, a finding which they say could lead to its early diagnosis and treatment.

Scientists have found five key signs of Alzheimer’s that can be detected up to 25 years before the onset of the degenerative disease, a finding which they say could lead to its early diagnosis and treatment.

A clinical trial of an Alzheimer’s disease treatment developed at MIT has found that the nutrient cocktail can improve memory in patients with early Alzheimer’s. The results confirm and expand the findings of an earlier trial of the nutritional supplement, which is designed to promote new connections between brain cells.
This enzyme is also involved in other conditions as inflammatory bowel disease or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington’s disease and amyotrophic lateral sclerosis.
University of Granada researchers have tested melatonin analogues in rats as it inhibits the enzyme nitric oxide synthase (NOS), which is involved in the development of conditions as inflammatory bowel disease, septic shock or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington’s disease, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis

Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer’s disease. The researchers’ findings, published in the journal Science, show that use of a drug in mice appears to quickly reverse the pathological, cognitive and memory deficits caused by the onset of Alzheimer’s. The results point to the significant potential that the medication, bexarotene, has to help the roughly 5.4 million Americans suffering from the progressive brain disease.

It sounds like science fiction, but neuroscientists have identified a molecule in mice that, when suppressed, significantly boosts memory. It’s meant as a radical treatment for Alzheimer’s patients, but there’s no reason the rest of us couldn’t take it, too. Baylor University researchers discovered that a molecule called PKR serves two crucial function in the brains of mice. In everyday situations, it’s concerned with regulating how neurons interact in memory-related tasks. But when a virus invades, PRK activates a stress response that alerts the rest of the brain that something is very wrong. Alzheimer’s sufferers also experience PKR-releasing stress in the course of their disease.